Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TVG's poultry vaccine is a preclinical-stage vaccine candidate developed by The Vaccine Group (TVG). It utilizes a proprietary herpesvirus-based viral-vector platform to deliver antigens from a specific, though currently undisclosed, poultry pathogen. The vaccine is designed to stimulate both cellular and humoral immune responses to provide protection against the target disease in poultry populations. This program represents an expansion of TVG's viral-vector technology from cattle and swine into avian health, leveraging the natural characteristics of herpesviruses to induce robust and long-lasting immunity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on TVG herpesvirus-vector poultry vaccine.